International Leprosy Association -
History of Leprosy

  • International Leprosy Association -
    History of Leprosy


    Professor Samuel L Moschella

    Status Physician
    Country USA


    Samuel L Moschella is an eminent consultant dermatologist who has been a member of the International Leprosy Association since 1967.

    Samuel Moschella was born in East Boston, Massachusetts, in April 1921. He attended Tufts University (1940-6), where he gained an M.D. (Cum Laude). He subsequently specialized in dermatology, and became Chief of Dermatology and Assistant Chief of Medicine at the US Naval Hospital, Guantanamo Bay, Cuba in 1948-51. He later became Clinical Assistant of the Municipal Clinic for Leprosy and Syphilis at the same hospital in 1954-6, under the direction of Dr Jesus Pedroso Crucet.

    In 1962 he became a consultant for the US Public Health Service for Leprosy, at Carville in Baton Rouge, Louisiana, and was to continue his involvement with Carville for over thirty years. From 1962 to 1967 he was also Chairman of the Department of Dermatology at the US Naval Hospital in Philadelphia, and in 1967 he became Leprosy Consultant at the Brighton Marine Hospital (which is now the Lahey Clinic).

    From 1969 to 1982 he was Chairman of the Department of Dermatology at the Lahey Clinic. In 1972 he held three WHO Fellowships in leprosy, during which he worked with Dr Felton Ross for ALERT in Ethiopia, with Dr F Latapi in Mexico City, and with Dr J Convit in Caracas, Venezuela.

    From 1975 to 1991 he was a Clinical Professor at Harvard Medical School (Clinical Professor of Dermatology from 1982). He was President of the American Board of Dermatology in 1986-9.

    In 1992 Moschella received the Clarke W Finneraud Award and was also selected as a Master in Dermatology by the American Association of Dermatology, of which he had been a member for almost 40 years. He is also a member of the American Society of Dermatopathology, the International Leprosy Association, the Society of Investigative Dermatology, the American Dermatological Association, and the International Society of Dermatology.

    This entry was made 4 July, 2006.


    1. Moschella SL. “ The unitarian concept of the treponemal diseases” U S Armed Forces Med J, 7.8 (1956): 1101-8.
    2. Moschella SL. “Leprosy and the military physician” Mil Med. 131.6 (1966): 525-9.
    3. Moschella SL, Bell WR, Trautman JR. “The indirect basophil test in erythema nodosum leprosum” Int J Lepr. 34.1 (1966):39-41.
    4. Moschella SL, Wire GE. “Sensory radicular neuropathy of the hereditary type. A case report” Arch Dermatol. 94.4 (1966):449-53.
    5. Moschella SL. “Hidradenitis suppurativa. Complications resulting in death” JAMA, 198.1 (1966): 201-3.
    6. Moschella SL. “The lepra reaction with necrotizing skin lesions. A report of six cases” Arch Dermatol., 95.6 (1967):565-75.
    7. Moschella SL, Klein MH, Miller RJ. “Perifolliculitis capitis abscedens et suffodiens. Report of a successful therapeutic scalping” Arch Dermatol. 96.2 (1967): 195-7.
    8. Moschella SL. “Primary diffuse lepromatous leprosy with erythema necrotisans (lucio phenomenon)” Arch Dermatol, 97.5 (1968):593-4.
    9. Moschella SL. “The clinical significance of necrosis of the skin” Med Clin North Am, 53.2 (1969):259-74.
    10. Moschella SL. “Hidradenitis suppurative” inCurrent Therapy. Philadelphia: WB Saunders, 1969: pp. 609-610.
    11. Moschella SL. “Xanthomatosis, associated with multiple myeloma” Arch Dermatol 102.1 (1970):121-3.
    12. Moschella SL. “Cutaneous xanthomatoses: a review and their relationship with the current classification of the hyperlipoproteinemias” Lahey Clin Found Bull, 19.3 (1970):103-11.
    13. Moschella SL. “The charcot joint in leprosy” Cutis, 7 (1971):681-5.
    14. Moschella SL. “Case presentation (CPC-MGH) Mycosis fungoides” N Engl J Med, 285 (1971):1526-32.
    15. Moschella SL. “Leprosy in 1971. A review” Cutis, 10 (1972):27-50.
    16. Moschella SL. “Unusual clinical expressions of leprosy” Lahey Clinic Bull 20 (1972):143-149.
    17. McMeekin TO, Moschella SL. “Iatrogenic complications of dermatologic therapy” Med Clin of NA, 63 (1972).
    18. Moschella SL. “Cutaneous manifestations of internal malignancy” Med Clin North Am, 59.2 (1975):471-9.
    19. Moschella SL. “Hypersensitive and insensitive extremities. The dermatological aspects” Br J Dermatol 93.2 (1975):151-8.
    20. Moschella SL, Pillsbury DM and Hurley HJ (eds): Dermatology Volume I and II. Philadelphia: WB Saunders Co., 1975.
    21. Moschella SL. “Hypersensitivity and miscellaneous inflammatory disorders” in SL Moschella, DM Pillsbury and HJ Hurley (eds) Dermatology. Philadelphia: WB Saunders Co., 1975: pp. 385-408.
    22. Moschella SL (ed). Dermatology Update NY: Elsevier, 1979.
    23. Moschella SL. “Mycobacterial infection of skin” inDermatology Update, SL Moschella (ed). NY: Elsevier, 1979: pp. 45-67.
    24. Moschella SL. “Psoriasis” Pharmac Ther, 10 (1980):161-9.
    25. Tanghetti E, Moschella SL. “Pyoderma gangrenosum” Int Journ Derm (1982).
    26. Moschella SL. “Tuberculosis of the skin” in S Maddin, A Carruthers, TH Brown (eds), Current Dermatologic Therapy. Philadelphia: WB Saunders Co., 1982: p. 439.
    27. Moschella SL. “Erythema nodosum” in SS Gellis, and BM Kagan (eds) Current Pediatric Therapy. Philadelphia: WB Saunders Co., 1982: p. 439.
    28. Moschella SL. “Leprosy today” Australas J Dermatol, 24.2 (1983):47-54.
    29. Moschella SL. “Review of so-called aseptic neutrophilic dermatoses” Australas J Dermatol 24.2 (1983):55-62.
    30. Kerdel FA, Moschella SL. “Sarcoidosis. An updated review” J Am Acad Dermatol, 11.1 (1984):1-19.
    31. Moschella SL and Hurley HJ (eds). Dermatology, Second Edition. Philadelphia: WB Saunders Co., 1985.
    32. Moschella SL. “Diseases of the mononuclear phagocytic system (so-called reticuloendothelial system)” in SL Moschella and HJ Hurley (eds). Dermatology, Second Edition. Philadelphia: WB Saunders Co., 1985: pp. 890-999.
    33. Moschella SL. “Leishmaniasis” in TT Provost and EDR Farmer (eds), Current Therapy in Dermatology– 2. St. Louis: DV Mosby Co, 1988: pp. 199-201.
    34. Moschella SL. “Dermatologic overview of lupus erythematosus and its subsets” J Dermatol, 16.6 (1989):417-28.
    35. Moschella SL. “The retinoids: A clinical review” Saudi Medical Journal, 13 (1992):99-105.
    36. Moschella SL. “An overview of Vasculitis seen by the dermatologist” SaudiMedicalJournal (1992).
    37. Moschella SL and Hurley HJ (eds). Dermatology, Third Edition, Philadelphia: WB Saunders Co., 1992.
    38. Moschella SL: “Rheumatic diseases” in SL Moschella and HJ Hurley (eds), Dermatology, Third Edition. Philadelphia: WB Saunders Co., 1992: pp. 1256-1266.
    39. Moschella, SL. “Miscellaneous rheumatic disease that can involve the skin” in RD Sontheimer and TT Provost (eds), Cutaneous Manifestations of Rheumatic Diseases. Baltimore: Williams & Wilkins, 1996: pp. 257-283.
    40. Moschella SL. “Carville: 100 years of excellence” J Am Acad Dermatol, 36.1 (1997):126-30.
    41. Moschella SL. “Neutrophilic dermatoses” in JL Bolognia, JL Jorizzo, RP Rapini (eds), Dermatology. Mosby/Elsevier Limited, 2003: pp. 411-423.
    42. Moschella SL. “An update on the diagnosis and treatment of leprosy”, J Amer Acad Dermatol, 51.3 (2004): 417-427.
    43. Moschella SL, Kay J, Mackool B, Liu V. “Case 35-2004: A 68-year-old man with end-stage renal disease and thickening of the skin” N Eng J Med, 351 (2004):61-69.
    44. Moschella, SL. “Miscellaneous rheumatic disease that can involve the skin in RD Sontheimer and TT Provost (eds), Cutaneous Manifestations of Rheumatic Diseases, Second Edition. Baltimore: Lippincott, Williams & Wilkins, 2004: pp. 205-220.
    45. Moschella SL. “Is there a role for tumor necrosis factor-α inhibitors and especially thalidomide in dermatology?” Skin Med. 4 (2005):24-30.


    Carville   Was a involved with Carville as a consultant from 1962 to 1994.

    Go back to previous page.